NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.
NRx Pharmaceuticals has raised $22.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
NRx Pharmaceuticals's investors include Venture 76, B Capital, Columbia Threadneedle Investments, Streeterville Capital, Anson Funds.
NRx Pharmaceuticals is headquartered in Wilmington, United States.
NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.
NRx Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NRx Pharmaceuticals — Funding & Investors." VCBacked, June 3, 2026, https://www.vcbacked.co/company/nrx-pharmaceuticals. Accessed September 29, 2026.
VCBacked. (2026). NRx Pharmaceuticals — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/nrx-pharmaceuticals
{{cite web |title=NRx Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/nrx-pharmaceuticals |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated